August Bioservices Closes $23.6 Million Series A Extension To Expand U.S. Biopharma Manufacturing Capabilities
August Bioservices Closes $23.6 Million Series A Extension To Expand U.S. Biopharma Manufacturing Capabilities
05/27/21, 9:32 PM
Location
nashvilleRound Type
series a
August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined existing investor Oak HC/FT. The proceeds will go toward expanding August’s manufacturing capacity and capabilities to advance the technology platforms needed to support production of sterile injectable medications.
Company Info
Location
nashville, arkansas, united states
Additional Info
Headquartered in Nashville, TN, August Bioservices, LLC is a high-tech, growth-focused, and innovative provider of Contract Research, Development and Manufacturing services, that plays a crucial role in the global pharmaceutical industry supply chain. For the biotech and pharma companies it serves, August is a US-based outsourcing partner with state-of-the-art instrumentation, industry-leading technical expertise, and decades of finished dose pharmaceutical manufacturing experience.
For more information about August’s full line of services: www.augustbio.com.
For more information about August’s specialized services: www.augustbiospecializedservices.com.